CollPlant is a leading brand in the field of regenerative and aesthetic medicine. They specialize in developing innovative technologies and products for tissue regeneration and organ manufacturing. With a vision to be the leaders in regenerative medicine, CollPlant aims to improve the lives of individuals by utilizing their revolutionary plant-based technology.

One of their key products is rhCollagen, a recombinant human type I collagen that is identical to the collagen produced by the human body. This rhCollagen serves as the ideal building block for regenerative medicine. CollPlant leverages the unique properties of this collagen to develop a pipeline of products aimed at 3D bioprinting of tissues and organs, as well as medical aesthetics such as regenerative dermal fillers and breast implants.

Their BioInk platform, Collink. 3D, is based on recombinant human collagen and is designed for use in 3D bioprinting. It accurately mimics the physical properties of human tissues and organs, enabling the development of 3D bioprinted scaffolds.

CollPlant is committed to staying at the forefront of regenerative medicine, with multiple patent families filed, peer-reviewed publications, and extensive clinical experience. They continue to collaborate with partners and drive advancements in the field